Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Biol Interact ; 382: 110610, 2023 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-37348670

RESUMO

Quercetin is a flavonol widely distributed in plants and has various described biological functions. Several studies have reported on its ability to restore neuronal function in a wide variety of disease models, including animal models of neurodegenerative disorders such as Parkinson's disease. Quercetin per se can act as a neuroprotector/neuromodulator, especially in diseases related to impaired dopaminergic neurotransmission. However, little is known about how quercetin interacts with the dopaminergic machinery. Here we employed the nematode Caenorhabditis elegans to study this putative interaction. After observing behavioral modulation, mutant analysis and gene expression in C. elegans upon exposure to quercetin at a concentration that does not protect against MPTP, we constructed a homology-based dopamine transporter protein model to conduct a docking study. This led to suggestive evidence on how quercetin may act as a dopaminergic modulator by interacting with C. elegans' dopamine transporter and alter the nematode's exploratory behavior. Consistent with this model, quercetin controls C. elegans behavior in a way dependent on the presence of both the dopamine transporter (dat-1), which is up-regulated upon quercetin exposure, and the dopamine receptor 2 (dop-2), which appears to be mandatory for dat-1 up-regulation. Our data propose an interaction with the dopaminergic machinery that may help to establish the effects of quercetin as a neuromodulator.


Assuntos
Dopamina , Quercetina , Transmissão Sináptica , Animais , Caenorhabditis elegans , Quercetina/farmacologia , Dopamina/metabolismo , Proteínas de Caenorhabditis elegans , Fármacos Neuroprotetores/farmacologia , Proteínas da Membrana Plasmática de Transporte de Dopamina/metabolismo , Neurônios/metabolismo , Estresse Oxidativo , Transmissão Sináptica/efeitos dos fármacos , Receptores de Dopamina D2/metabolismo , 1-Metil-4-Fenil-1,2,3,6-Tetra-Hidropiridina
2.
J Food Biochem ; 44(3): e13139, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31899557

RESUMO

Butiá (Butia eriospatha) is a fruit of a palm tree belonging to the family Arecaceae, native to South America. The aim of this study was to evaluate the antioxidant potential of butiá extract using Caenorhabditis elegans as animal model. Initially, we performed survival experiments, reproduction, resistance to oxidative stress (post or pre-treatment with paraquat or hydrogen peroxide), longevity, superoxide dismutase, and catalase GFP reporters' expression. We observed that butiá extract did not affect the worms' survival. Similarly, egg laying also showed no significant difference between treatments. None of the extract concentrations tested was able to significantly protect or reverse paraquat-induced oxidative stress. However, they were able to reverse the oxidative damage induced by hydrogen peroxide. In addition, butiá extract increased C. elegans lifespan under stress and not per se. Our results demonstrate that the Butiá is able to extend the lifespan of the nematode C. elegans and that this effect may be mediated by an induced resistance to oxidative stress. PRACTICAL APPLICATIONS: The practical applications of this research are to expand and bring scientific knowledge to the population about the benefits of the consumption of this native fruit from the southern region of Brazil. Many fruits and other plant foods are consumed and spread with benefits without proper scientific proof of these benefits. This fruit is widely cultivated and its production and consumption can be expanded from these results. Still, we point out that this is the first time that the benefits of this fruit are studied.


Assuntos
Arecaceae , Caenorhabditis elegans , Animais , Frutas , Longevidade , Estresse Oxidativo , Extratos Vegetais/farmacologia
3.
J Trace Elem Med Biol ; 53: 34-40, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30910204

RESUMO

Organic selenium compounds have several pharmacological activities already described, as anti-inflammatory and antitumor activities, which have been attributed to their antioxidant effects. Because they are promising in pharmacology, the synthesis of these compounds has increased significantly. As many new molecules are synthesized the use of a simple model like Caenorhabditis elegans is highly advantageous for initial evaluation of the toxicity and therapeutic potential of these molecules. The objective of this study was to evaluate the toxicity and antioxidant capacity of a series of selenotriazoles compounds in C. elegans. The animals were exposed to the compounds in liquid medium for only 30 min at the first larval stage (L1). The compounds had no toxic effects at the concentrations tested. Treatment with selenotriazoles (10 µM) partially reversed the stress induced by the pesticide paraquat (1 mM). Se-Tz Ia compound partially increased the survival of worms treated with H2O2 (0.5 mM). The compounds also increased the longevity of mev-1 mutants, which have a reduced life span by the production of excessive reactive oxygen species (ROS) in the mitochondria caused by a mutation in complex II of the electron transport chain. In addition, the compounds reduced the levels of ROS determined by the fluorescent probe DCF-DA as well as also reduced catalase enzyme activity in these animals. Based on the results found, it is possible to conclude that the compounds have antioxidant activity mainly in oxidative stress condition generated by a mitochondrial dysfunction in C. elegans.


Assuntos
Azidas/farmacologia , Proteínas de Caenorhabditis elegans/genética , Caenorhabditis elegans/efeitos dos fármacos , Citocromos b/genética , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Mutação , Estresse Oxidativo/efeitos dos fármacos , Compostos de Selênio/farmacologia , Animais , Azidas/química , Caenorhabditis elegans/citologia , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/metabolismo , Citocromos b/metabolismo , Mitocôndrias/metabolismo , Estrutura Molecular , Espécies Reativas de Oxigênio/análise , Espécies Reativas de Oxigênio/metabolismo , Compostos de Selênio/química
4.
J Nanosci Nanotechnol ; 16(2): 1257-64, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27433575

RESUMO

The aim of this work was to develop and characterize clozapine loaded polysorbate-coated polymeric nanocapsules and assess their toxicity in Caenorhabditis elegans, an invertebrate animal model. Formulations were prepared by nanoprecipitation method and characterized by particle size, zeta potential, pH, drug loading, entrapment efficiency and in vitro drug release. All nanocapsules prepared presented diameter around 140 nm, pH slightly acid and negative zeta potential. In vitro studies showed biphasic drug release from nanocapsules with decreasing of the release rate on nanoencapsulation. The t(1/2)beta of clozapine was 7.23 +/- 0.73 and 2.23 +/- 0.97 h for nanoencapsulated and free drug, respectively (p < 0.05), in pH 1.2 medium. Similar results were obtained in pH 6.8 buffer. Regarding toxicity evaluation, worms exposed to clozapine-loaded nanocapsules did not show the same mortality rate compared to others formulations, as the survival was significantly higher than the free drug treated-group. In addition, we observed that free clozapine decreased egg laying at the first reproductive day, whereas nanoencapsulated clozapine did not depict significant change of this parameter. Longevity assay showed no significant difference, demonstrating that the toxicological effects of clozapine observed in C. elegans are acute. In addition, we proved that free and nanoencapsulated clozapine were orally uptake by the worms, as determined by fluorescein-labeled nanocapsules. Then, the use of nanocapsules delayed the drug release and minimized the toxic effects of clozapine in worms, which can be used as a new animal model to evaluate the nanotoxicity of drug delivery systems.


Assuntos
Caenorhabditis elegans/metabolismo , Clozapina , Nanocápsulas/química , Animais , Clozapina/efeitos adversos , Clozapina/química , Clozapina/farmacocinética , Clozapina/farmacologia , Preparações de Ação Retardada/efeitos adversos , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Avaliação Pré-Clínica de Medicamentos , Tamanho da Partícula
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...